Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia.

García Porrúa C, Maceiras Pan FJ, Mosquera Martínez JA, Carmona L, Correa Rey B, Fernández Domínguez L, Álvarez Rivas MN, Pinto Tasende JA.

Reumatol Clin. 2019 Jun 27. pii: S1699-258X(19)30103-2. doi: 10.1016/j.reuma.2019.04.006. [Epub ahead of print] English, Spanish.

2.

Quality Standard for the Management of Patients with Psoriatic Arthritis: QUANTUM Project.

Sanz Sanz J, Beltrán E, Díaz-Miguel Pérez MC, Fernández-Carballido C, Galíndez E, García Porrua C, Gratacós J, Medina J, Queiro R, Ramírez J, Reina D, Rodríguez Lozano C, Rodríguez Martínez FJ, Rubio E, Veroz R.

Reumatol Clin. 2018 Jul 24. pii: S1699-258X(18)30129-3. doi: 10.1016/j.reuma.2018.06.011. [Epub ahead of print] English, Spanish.

3.

Tumor-induced hypophosphatemic osteomalacia: description of 2 cases.

Alvarez-Rivas N, Vazquez-Rodriguez TR, Garcia-Porrua C.

Med Clin (Barc). 2019 Jan 4;152(1):e3-e4. doi: 10.1016/j.medcli.2018.04.010. English, Spanish. No abstract available.

PMID:
29776656
4.

[Prevalence of osteoporosis, estimation of probability of fracture and bone metabolism study in patients with newly diagnosed prostate cancer in the health area of Lugo].

Miguel-Carrera J, García-Porrua C, de Toro Santos FJ, Picallo-Sánchez JA.

Aten Primaria. 2018 Mar;50(3):176-183. doi: 10.1016/j.aprim.2017.03.006. Epub 2017 Jun 17. Spanish.

5.

Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients.

Alvarez Rivas N, Vazquez Rodriguez TR, Miranda Filloy JA, Garcia-Porrua C, Sanchez-Andrade Fernández A.

Reumatol Clin. 2019 Jan - Feb;15(1):54-57. doi: 10.1016/j.reuma.2017.04.007. Epub 2017 May 25. English, Spanish.

6.

HLA-DRB1* association with sarcoidosis.

Gonzalez-Gay MA, Lopez-Mejias R, Garcia-Porrua C.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):298. Epub 2013 Dec 2. No abstract available.

PMID:
24295517
7.

Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis.

Gonzalez-Gay MA, Garcia-Porrua C, Gonzalez-Juanatey C, Miranda-Filloy JA, Blanco R, Llorca J.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S94. Epub 2013 Mar 4. No abstract available.

PMID:
23463922
8.

[Erythema nodosum as a presentation form of hepatitis B and acute leukemia].

Ventura Valcárcel P, García Porrúa C.

Rev Clin Esp (Barc). 2013 Mar;213(2):124-5. doi: 10.1016/j.rce.2012.10.002. Epub 2012 Dec 27. Spanish. No abstract available.

PMID:
23273972
9.

Brucellosis is not only responsible for monoarthritis but it is also associated with other osteoarticular complications.

González-Gay MA, García-Porrúa C.

Rheumatol Int. 2014 Jan;34(1):133. doi: 10.1007/s00296-012-2596-9. Epub 2012 Dec 14. No abstract available.

PMID:
23239040
10.

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gomez-Acebo I, Testa A, Garcia-Porrua C, Sanchez-Andrade A, Llorca J, González-Gay MA.

Mediators Inflamm. 2012;2012:674265. doi: 10.1155/2012/674265. Epub 2012 Jul 31.

11.

Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis.

Afonso Pérez E, Garcia Porrua C, Castiñeiras Mato IM, Bal Nieves F.

Reumatol Clin. 2012 Nov-Dec;8(6):380-1. doi: 10.1016/j.reuma.2012.05.009. Epub 2012 Aug 2. English, Spanish. No abstract available.

12.

Crowned dens syndrome resembling meningitis as the first manifestation of calcium crystal deposition disease.

Arauz-Rivera R, Garcia-Porrua C.

J Am Geriatr Soc. 2012 Feb;60(2):374-5. doi: 10.1111/j.1532-5415.2011.03811.x. No abstract available.

PMID:
22332683
13.

[Synovial sarcomas in Lugo between 2002-2006].

Bravo-Pérez M, López-López S, Miranda-Filloy A, Ibáñez-Martín L, Quevedo-García L, García-Porrua C.

Reumatol Clin. 2009 Sep-Oct;5(5):194-6. doi: 10.1016/j.reuma.2008.12.010. Epub 2009 Jul 9. Spanish.

14.

Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein pur pura.

Amoli MM, Martin J, Miranda-Filloy JA, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S6-9.

PMID:
17428355
15.

Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases.

Olivieri I, Garcia-Porrua C, Padula A, Cantini F, Salvarani C, Gonzalez-Gay MA.

Rheumatol Int. 2007 Aug;27(10):927-33. Epub 2007 Apr 11.

PMID:
17426977
16.

Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.

Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA.

Arthritis Rheum. 2007 Mar 15;57(2):287-93.

17.

HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J.

Arthritis Rheum. 2007 Feb 15;57(1):125-32.

18.

Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis.

Miranda-Filloy JA, Veiga JA, Juarez Y, Gonzalez-Juanatey C, Gonzalez-Gay MA, Garcia-Porrua C.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6):705-6.

PMID:
17207390
19.

A case of Whipple disease with pleural effusion diagnosed by means of PCR.

Garcia-Porrua C, Arias C, Veiga JA, Santos E, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):606. No abstract available.

PMID:
17181935
20.

Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.

Amoli MM, Martin J, Miranda-Filloy JA, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):576-9.

PMID:
17181929
21.

Cardiovascular disease in rheumatoid arthritis.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J.

Biomed Pharmacother. 2006 Dec;60(10):673-7. Epub 2006 Oct 10. Review.

PMID:
17049201
22.

Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.

Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, Fernández O, Garcia-Porrua C, Gonzalez-Escribano MF, Martín J.

Rheumatology (Oxford). 2007 Mar;46(3):431-4. Epub 2006 Sep 26.

PMID:
17003171
23.

Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.

Drugs Aging. 2006;23(8):627-49. Review.

PMID:
16964987
24.

Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J.

Clin Exp Rheumatol. 2006 Jul-Aug;24(4):373-9.

PMID:
16956426
25.

Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.

Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2006 May-Jun;24(3):309-12.

PMID:
16870100
26.

Bilateral vertebral artery occlusion in giant cell arteritis.

Garcia-Porrua C, Pego-Reigosa R, Martinez-Vazquez F, Armesto V, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S101. No abstract available.

PMID:
16859605
27.

Giant cell arteritis: diagnosis and therapeutic management.

Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA.

Curr Rheumatol Rep. 2006 Aug;8(4):299-302. Review.

PMID:
16839509
28.

Localized vasculitis of the gastrointestinal tract.

Garcia-Porrua C, Gutierrez-Duque O, Soto S, Garcia-Rodeja E, Gonzalez-Gay MA.

Semin Arthritis Rheum. 2006 Jun;35(6):403-6.

PMID:
16765718
29.

Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.

Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA.

Semin Arthritis Rheum. 2006 Apr;35(5):333-9.

PMID:
16616156
30.

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):83-6.

PMID:
16539824
31.

Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?

Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V.

J Rheumatol. 2006 Feb;33(2):433; author reply 433-4. No abstract available.

PMID:
16465676
32.

Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.

Martin J, Perez-Armengol C, Miranda-Filloy JA, Vilchez JR, Lopez-Nevot MA, Garcia-Porrua C, Gonzalez-Gay MA.

J Rheumatol. 2006 Feb;33(2):285-8.

PMID:
16465659
33.

Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.

Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA.

Arthritis Rheum. 2006 Feb 15;55(1):150-3. No abstract available.

34.

Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis.

Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, Martín J, Gonzalez-Gay MA.

J Rheumatol. 2006 Jan;33(1):74-8.

PMID:
16395753
35.

Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura.

Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martín J, Gonzalez-Gay MA.

J Rheumatol. 2006 Jan;33(1):69-73.

PMID:
16395752
36.

Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.

Gonzalez-Gay MA, Oliver J, Sanchez E, Garcia-Porrua C, Paco L, Lopez-Nevot MA, Ollier WE, Martin J.

J Rheumatol. 2005 Nov;32(11):2178-82.

PMID:
16265698
37.

Superficial collections of fluid tophaceous material as clinical presentation of anorexia nervosa.

Garcia-Porrua C, Canedo C, Argueso R, Gonzalez-Gay MA.

Ann Rheum Dis. 2005 Nov;64(11):1658-9. No abstract available.

38.

Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity.

Orozco G, García-Porrúa C, López-Nevot MA, Raya E, González-Gay MA, Martín J.

Ann Rheum Dis. 2006 May;65(5):687-8. Epub 2005 Sep 8. No abstract available.

39.

Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients.

Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J.

Medicine (Baltimore). 2005 Sep;84(5):277-90.

40.

Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J.

Medicine (Baltimore). 2005 Sep;84(5):269-76.

41.

A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.

Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martín J, Gonzalez-Gay MA.

J Rheumatol. 2005 Sep;32(9):1737-41.

PMID:
16142870
42.

Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis.

Gonzalez-Gay MA, Oliver J, Orozco G, Garcia-Porrua C, Lopez-Nevot MA, Martin J.

J Rheumatol. 2005 Aug;32(8):1510-2.

PMID:
16078327
43.

[Cerebrovascular disease as the presenting symptom of temporal arteritis].

Pego-Reigosa R, Vázquez-López ME, García-Porrúa C, González-Gay MA.

Rev Neurol. 2005 Aug 1-15;41(3):191-2. Spanish. No abstract available.

44.

High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrua C, Testa A, Llorca J.

J Rheumatol. 2005 Jul;32(7):1219-23.

PMID:
15996055
45.

Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain.

Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calviño MC, Ollier WE, Gonzalez-Gay MA.

J Rheumatol. 2005 Jun;32(6):1081-5.

PMID:
15940772
46.

Supraclavicular pulsatile mass as presenting sign of brachiocephalic trunk aneurysm in the long-term followup of giant cell arteritis.

Garcia-Porrua C, Pego-Reigosa R, Piñeiro A, Armesto V, González-Gay MA.

Arthritis Rheum. 2005 Jun 15;53(3):475-6. No abstract available.

47.

Altitude and giant cell arteritis.

Llorca J, Bringas-Bollada M, Garcia-Porrua C, Gonzalez-Gay MA.

J Rheumatol. 2005 May;32(5):963-4; author reply 964. No abstract available.

PMID:
15868602
48.

Magnetic resonance imaging in optic neuritis due to giant cell arteritis.

Garcia-Porrua C, Santamarina R, Armesto V, Gonzalez-Gay MA.

Arthritis Rheum. 2005 Apr 15;53(2):313-4. No abstract available.

49.

Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.

Gonzalez-Gay MA, Rubiera G, Piñeiro A, Garcia-Porrua C, Pego-Reigosa R, Gonzalez-Juanatey C, Sanchez-Andrade A, Llorca J.

J Rheumatol. 2005 Mar;32(3):502-6.

PMID:
15742443
50.

Pacemaker infection due to Aspergillus: report of two cases and literature review.

Izquierdo R, Llorente C, Mayo J, Garcia-Porrua C, Gonzalez-Juanatey C, Gonzalez-Gay MA.

Clin Cardiol. 2005 Jan;28(1):36-8. Review.

Supplemental Content

Loading ...
Support Center